Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Impact of schizophrenia and related disorders on mortality from breast cancer : A population-based cohort study in Denmark, 1995-2011. / Dalton, Susanne Oksbjerg; Suppli, Nis Palm; Ewertz, Marianne; Kroman, Niels; Grassi, Luigi; Johansen, Christoffer.
I: The Breast, Bind 40, 2018, s. 170-176.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Impact of schizophrenia and related disorders on mortality from breast cancer
T2 - A population-based cohort study in Denmark, 1995-2011
AU - Dalton, Susanne Oksbjerg
AU - Suppli, Nis Palm
AU - Ewertz, Marianne
AU - Kroman, Niels
AU - Grassi, Luigi
AU - Johansen, Christoffer
N1 - Copyright © 2018. Published by Elsevier Ltd.
PY - 2018
Y1 - 2018
N2 - OBJECTIVES: To investigate overall and breast cancer-specific mortality in early-stage breast cancer patients with and without schizophrenia or related disorders.METHODS: We used Danish national registers to identify all women with no prior history of cancer or organic mental disorders, who were diagnosed with early-stage breast cancer 1995-2011. Logistic regression models were used to calculate the odds ratios (ORs) for not being allocated to guideline treatment. Cox regression models were used to compute hazard ratios (HRs) for overall and breast cancer-specific deaths among women allocated or not allocated to guideline treatment.RESULTS: We identified 56,152 women with early-stage breast cancer diagnosed in 1995-2011, of whom 499 women also had been diagnosed with schizophrenia or related disorders. The likelihood of women with schizophrenia or related disorders for not being allocated to guideline treatment was increased (adjusted OR, 1.50; 95% confidence interval (CI), 1.15-1.94). The adjusted HR for all-cause mortality was 1.55; 95% CI, 1.32-1.82 and 1.12 (95% CI, 0.98-1.50) for breast cancer-specific mortality; women allocated to guideline treatment had an adjusted HR for breast cancer-specific death of 1.42 (95% CI, 1.11-1.82). The adjusted HR for death due to unnatural causes was 3.67 (95% CI, 1.80-7.35).CONCLUSION: The survival of women with schizophrenia or related disorders after breast cancer is significantly worse than that of women without these disorders. These patients are less likely to be allocated to guideline treatment, and, among those who are, mortality from both breast cancer and other causes is increased.
AB - OBJECTIVES: To investigate overall and breast cancer-specific mortality in early-stage breast cancer patients with and without schizophrenia or related disorders.METHODS: We used Danish national registers to identify all women with no prior history of cancer or organic mental disorders, who were diagnosed with early-stage breast cancer 1995-2011. Logistic regression models were used to calculate the odds ratios (ORs) for not being allocated to guideline treatment. Cox regression models were used to compute hazard ratios (HRs) for overall and breast cancer-specific deaths among women allocated or not allocated to guideline treatment.RESULTS: We identified 56,152 women with early-stage breast cancer diagnosed in 1995-2011, of whom 499 women also had been diagnosed with schizophrenia or related disorders. The likelihood of women with schizophrenia or related disorders for not being allocated to guideline treatment was increased (adjusted OR, 1.50; 95% confidence interval (CI), 1.15-1.94). The adjusted HR for all-cause mortality was 1.55; 95% CI, 1.32-1.82 and 1.12 (95% CI, 0.98-1.50) for breast cancer-specific mortality; women allocated to guideline treatment had an adjusted HR for breast cancer-specific death of 1.42 (95% CI, 1.11-1.82). The adjusted HR for death due to unnatural causes was 3.67 (95% CI, 1.80-7.35).CONCLUSION: The survival of women with schizophrenia or related disorders after breast cancer is significantly worse than that of women without these disorders. These patients are less likely to be allocated to guideline treatment, and, among those who are, mortality from both breast cancer and other causes is increased.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Breast Neoplasms/mortality
KW - Cohort Studies
KW - Denmark/epidemiology
KW - Female
KW - Humans
KW - Logistic Models
KW - Middle Aged
KW - Odds Ratio
KW - Proportional Hazards Models
KW - Registries
KW - Risk Factors
KW - Schizophrenia/complications
U2 - 10.1016/j.breast.2018.06.002
DO - 10.1016/j.breast.2018.06.002
M3 - Journal article
C2 - 29902718
VL - 40
SP - 170
EP - 176
JO - Breast
JF - Breast
SN - 0960-9776
ER -
ID: 222165648